The DOI matches its Crossref record; 178 of the 178 references it cites were found in a registry or an index.
Tumor angiogenesis and vascular normalization: alternative therapeutic targets
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The biology of VEGF and its receptors
Ferrara, N., Gerber, H.-P., & LeCouter, J. (2003) · Nature Medicine · doi:10.1038/nm0603-669 · Cited by 9,591 · cited 1×
“VEGFR1 has weak kinase activity with a strong affinity for VEGF and can act as a decoy receptor, competitively reducing VEGF binding to VEGFR2 and therefore regulating VEGF signaling in ECs [12].”
BackgroundNormalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527 · cited 1×
“It has been suggested that anti-angiogenic therapies could correct the structural and functional flaws of tumor blood vessels, a process referred to as ‘‘vascular normalization’’ [3, 4].”
BackgroundMolecular mechanisms and clinical applications of angiogenesis
Carmeliet, P., & Jain, R. K. (2011) · Nature · doi:10.1038/nature10144 · Cited by 5,467 · cited 1×
“platelet-derived growth factor (PDGF-B) and transforming growth factor (TGF-b) families, have also been implicated in the formation of a defective vascular network in tumors [2].”
BackgroundCuriel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., et al. (2004) · Nature Medicine · doi:10.1038/nm1093 · Cited by 5,151
Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V., & Ferrara, N. (1989) · Science · doi:10.1126/science.2479986 · Cited by 4,986
Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma
Escudier, B., Eisen, T., Stadler, W. M., Szczylik, C., Oudard, S., Siebels, M., Negrier, S., Chevreau, C., Solska, E., Desai, A. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa060655 · Cited by 4,802
Tumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites Fluid
Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S., & Dvorak, H. F. (1983) · Science · doi:10.1126/science.6823562 · Cited by 3,972
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
Miller, K., Wang, M., Gralow, J., Dickler, M., Cobleigh, M., Perez, E. A., Shenkier, T., Cella, D., & Davidson, N. E. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072113 · Cited by 3,081
Modes of resistance to anti-angiogenic therapy
Bergers, G., & Hanahan, D. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2442 · Cited by 2,953 · cited 1×
“Finally, the benefits of anti-VEGF are transitory and are followed by a resumption of tumor growth due to adaptive resistance or preexisting non-responsiveness [115].”
BackgroundVEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia
Gerhardt, H., Golding, M., Fruttiger, M., Ruhrberg, C., Lundkvist, A., Abramsson, A., Jeltsch, M., Mitchell, C., Alitalo, K., Shima, D., et al. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200302047 · Cited by 2,894
Role of platelet-derived growth factors in physiology and medicine
Andrae, J., Gallini, R., & Betsholtz, C. (2008) · Genes & Development · doi:10.1101/gad.1653708 · Cited by 2,438
Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., & Giaccia, A. J. (1996) · Nature · doi:10.1038/379088a0 · Cited by 2,300 · cited 2×
“increased tumor hypoxia and favor the selection of invasive tumor cells, enhancing the risks of metastatic spread [106, 107].”
BackgroundHigh Interstitial Fluid Pressure - an Obstacle in Cancer Therapy
Heldin, C.-H., Rubin, K., Pietras, K., & Östman, A. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1456 · Cited by 2,222 · cited 3×
“Interestingly, the remaining uncompressed vessels often display excessive blood flow, which contributes to the increased IFP in tumors [46].”
BackgroundInfluentialNormalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy
Jain, R. K. (2001) · Nature Medicine · doi:10.1038/nm0901-987 · Cited by 2,184
Vascular Channel Formation by Human Melanoma Cells in Vivo and in Vitro: Vasculogenic Mimicry
Maniotis, A. J., Folberg, R., Hess, A., Seftor, E. A., Gardner, L. M. G., Pe'er, J., Trent, J. M., Meltzer, P. S., & Hendrix, M. J. C. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65173-5 · Cited by 2,043
HIF-1α pathway: role, regulation and intervention for cancer therapy
Masoud, G. N., & Li, W. (2015) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2015.05.007 · Cited by 1,871 · cited 1×
“Recently, it was demonstrated that the ERK signaling cascade can result in the increased rate of mRNA translation of HIF1 protein [51].”
BackgroundLyden, D., Hattori, K., Dias, S., Costa, C., Blaikie, P., Butros, L., Chadburn, A., Heissig, B., Marks, W., Witte, L., et al. (2001) · Nature Medicine · doi:10.1038/nm1101-1194 · Cited by 1,860 · cited 1×
“Multiple studies have been published in the last fifteen years describing the involvement of endothelial precursor cells (EPC) in tumor angiogenesis [68, 69].”
BackgroundBatchelor, T. T., Sorensen, A. G., di Tomaso, E., Zhang, W.-T., Duda, D. G., Cohen, K. S., Kozak, K. R., Cahill, D. P., Chen, P.-J., Zhu, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.021 · Cited by 1,769
Filopodia: molecular architecture and cellular functions
Mattila, P. K., & Lappalainen, P. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2406 · Cited by 1,719
Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
Carmeliet, P., & Jain, R. K. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3455 · Cited by 1,675
Normalization of the Vasculature for Treatment of Cancer and Other Diseases
Goel, S., Duda, D. G., Xu, L., Munn, L. L., Boucher, Y., Fukumura, D., & Jain, R. K. (2011) · Physiological Reviews · doi:10.1152/physrev.00038.2010 · Cited by 1,605
Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
Jain, R. K. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.10.006 · Cited by 1,589 · cited 1×
“Another challenge in the use of VEGF inhibitors to obtain vascular normalization is achieving what has been referred to as a ‘‘window of opportunity,’’ which is the time frame and dosage of VEGF inhibitor administration required to observe normalization of tumor blood vessels [5].”
BackgroundThe role of pericytes in blood-vessel formation and maintenance
Bergers, G., & Song, S. (2005) · Neuro-Oncology · doi:10.1215/s1152851705000232 · Cited by 1,584
Reck, M., von Pawel, J., Zatloukal, P., Ramlau, R., Gorbounova, V., Hirsh, V., Leighl, N., Mezger, J., Archer, V., Moore, N., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.5466 · Cited by 1,505
Endothelial Cell Migration During Angiogenesis
Lamalice, L., Le Boeuf, F., & Huot, J. (2007) · Circulation Research · doi:10.1161/01.res.0000259593.07661.1e · Cited by 1,482
Control of vascular morphogenesis and homeostasis through the angiopoietin–Tie system
Augustin, H. G., Young Koh, G., Thurston, G., & Alitalo, K. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2639 · Cited by 1,465
Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells
Ricci-Vitiani, L., Pallini, R., Biffoni, M., Todaro, M., Invernici, G., Cenci, T., Maira, G., Parati, E. A., Stassi, G., Larocca, L. M., et al. (2010) · Nature · doi:10.1038/nature09557 · Cited by 1,379
Bergers, G., Song, S., Meyer-Morse, N., Bergsland, E., & Hanahan, D. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17929 · Cited by 1,370
Movahedi, K., Laoui, D., Gysemans, C., Baeten, M., Stangé, G., Van den Bossche, J., Mack, M., Pipeleers, D., In't Veld, P., De Baetselier, P., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4672 · Cited by 1,239
Corzo, C. A., Condamine, T., Lu, L., Cotter, M. J., Youn, J.-I., Cheng, P., Cho, H.-I., Celis, E., Quiceno, D. G., Padhya, T., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100587 · Cited by 1,173
Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation
Winkler, F., Kozin, S. V., Tong, R. T., Chae, S.-S., Booth, M. F., Garkavtsev, I., Xu, L., Hicklin, D. J., Fukumura, D., di Tomaso, E., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.10.011 · Cited by 1,170
Ohtsu, A., Shah, M. A., Van Cutsem, E., Rha, S. Y., Sawaki, A., Park, S. R., Lim, H. Y., Yamada, Y., Wu, J., Langer, B., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.2236 · Cited by 1,110
The Notch Ligands Dll4 and Jagged1 Have Opposing Effects on Angiogenesis
Benedito, R., Roca, C., Sörensen, I., Adams, S., Gossler, A., Fruttiger, M., & Adams, R. H. (2009) · Cell · doi:10.1016/j.cell.2009.03.025 · Cited by 1,107
Huang, Y., Yuan, J., Righi, E., Kamoun, W. S., Ancukiewicz, M., Nezivar, J., Santosuosso, M., Martin, J. D., Martin, M. R., Vianello, F., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1215397109 · Cited by 1,099
The Role of Mechanical Forces in Tumor Growth and Therapy
Jain, R. K., Martin, J. D., & Stylianopoulos, T. (2014) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071813-105259 · Cited by 1,044 · cited 6×
“In addition, compressive stress inhibits lymphatic network functionality and hinders the drainage of excessive interstitial fluid [43].”
BackgroundInfluentialBray, S. J. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.94 · Cited by 1,012 · cited 2×
“Dll4 binds Notch1 in neighboring ECs, leading to the cleavage and release of the Notch1 intracellular domain (NICD) [9].”
BackgroundAbnormalities in Pericytes on Blood Vessels and Endothelial Sprouts in Tumors
Morikawa, S., Baluk, P., Kaidoh, T., Haskell, A., Jain, R. K., & McDonald, D. M. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64920-6 · Cited by 983
Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting
Jakobsson, L., Franco, C. A., Bentley, K., Collins, R. T., Ponsioen, B., Aspalter, I. M., Rosewell, I., Busse, M., Thurston, G., Medvinsky, A., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2103 · Cited by 971
Crossing the endothelial barrier during metastasis
Reymond, N., d'Água, B. B., & Ridley, A. J. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3628 · Cited by 922 · cited 1×
“Hypoxic tumor cells often show a more aggressive phenotype, activating oncogenes and undergoing an ‘‘epithelial to mesenchymal transition’’ (EMT), which heightens their metastatic potential [44].”
BackgroundAngiogenesis: A Team Effort Coordinated by Notch
Phng, L.-K., & Gerhardt, H. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.01.015 · Cited by 832
Antiangiogenic therapy in oncology: current status and future directions
Jayson, G. C., Kerbel, R., Ellis, L. M., & Harris, A. L. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01088-0 · Cited by 828
Mazzone, M., Dettori, D., Leite de Oliveira, R., Loges, S., Schmidt, T., Jonckx, B., Tian, Y.-M., Lanahan, A. A., Pollard, P., Ruiz de Almodovar, C., et al. (2009) · Cell · doi:10.1016/j.cell.2009.01.020 · Cited by 812
Dejana, E., Tournier-Lasserve, E., & Weinstein, B. M. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.01.004 · Cited by 788
Rho GTPase signalling in cell migration
Ridley, A. J. (2015) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2015.08.005 · Cited by 778
Nalluri, S. R., Chu, D., Keresztes, R., Zhu, X., & Wu, S. (2008) · JAMA · doi:10.1001/jama.2008.656 · Cited by 771
Inai, T., Mancuso, M., Hashizume, H., Baffert, F., Haskell, A., Baluk, P., Hu-Lowe, D. D., Shalinsky, D. R., Thurston, G., Yancopoulos, G. D., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63273-7 · Cited by 757
Holash, J., Wiegand, S. J., & Yancopoulos, G. D. (1999) · Oncogene · doi:10.1038/sj.onc.1203035 · Cited by 744
Antiangiogenic therapy: impact on invasion, disease progression, and metastasis
Ebos, J. M. L., & Kerbel, R. S. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.21 · Cited by 685 · cited 1×
“increased tumor hypoxia and favor the selection of invasive tumor cells, enhancing the risks of metastatic spread [106, 107].”
BackgroundMosaic blood vessels in tumors: Frequency of cancer cells in contact with flowing blood
Chang, Y. S., di Tomaso, E., McDonald, D. M., Jones, R., Jain, R. K., & Munn, L. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.26.14608 · Cited by 671
Vascular Normalization as an Emerging Strategy to Enhance Cancer Immunotherapy
Huang, Y., Goel, S., Duda, D. G., Fukumura, D., & Jain, R. K. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4354 · Cited by 669
Endothelial Progenitor Cells Control the Angiogenic Switch in Mouse Lung Metastasis
Gao, D., Nolan, D. J., Mellick, A. S., Bambino, K., McDonnell, K., & Mittal, V. (2008) · Science · doi:10.1126/science.1150224 · Cited by 632
A role for VEGF as a negative regulator of pericyte function and vessel maturation
Greenberg, J. I., Shields, D. J., Barillas, S. G., Acevedo, L. M., Murphy, E., Huang, J., Scheppke, L., Stockmann, C., Johnson, R. S., Angle, N., et al. (2008) · Nature · doi:10.1038/nature07424 · Cited by 629
VEGF and Notch in Tip and Stalk Cell Selection
Blanco, R., & Gerhardt, H. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006569 · Cited by 620
Erber, R., Thurnher, A., D. Katsen, A., Groth, G., Kerger, H., Hammes, H., D. Menger, M., Ullrich, A., & Vajkoczy, P. (2004) · The FASEB Journal · doi:10.1096/fj.03-0271fje · Cited by 610
Tumour vascularization: sprouting angiogenesis and beyond
Hillen, F., & Griffioen, A. W. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9094-7 · Cited by 583
Abramsson, A., Lindblom, P., & Betsholtz, C. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18549 · Cited by 562
Targeting the PDGF signaling pathway in tumor treatment
Heldin, C.-H. (2013) · Cell Communication and Signaling · doi:10.1186/1478-811x-11-97 · Cited by 540
Scharpfenecker, M., van Dinther, M., Liu, Z., van Bezooijen, R. L., Zhao, Q., Pukac, L., Löwik, C. W. G. M., & ten Dijke, P. (2007) · Journal of Cell Science · doi:10.1242/jcs.002949 · Cited by 531
Abnormalities of Basement Membrane on Blood Vessels and Endothelial Sprouts in Tumors
Baluk, P., Morikawa, S., Haskell, A., Mancuso, M., & McDonald, D. M. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63540-7 · Cited by 528 · cited 2×
“the perivascular basement membrane can also present profound structural abnormalities with irregular thickness and some perforations [41, 42].”
BackgroundContribution of bone marrow–derived endothelial cells to human tumor vasculature
Peters, B. A., Diaz, L. A., Polyak, K., Meszler, L., Romans, K., Guinan, E. C., Antin, J. H., Myerson, D., Hamilton, S. R., Vogelstein, B., et al. (2005) · Nature Medicine · doi:10.1038/nm1200 · Cited by 482
HIF-1 and HIF-2 Transcription Factors - Similar but Not Identical
Loboda, A., Jozkowicz, A., & Dulak, J. (2010) · Molecules and Cells · doi:10.1007/s10059-010-0067-2 · Cited by 477 · cited 1×
“HIF-2a has a similar structure to HIF-1a but is only expressed in specific cells such as ECs and fibroblasts [172].”
BackgroundEndothelial adherens and tight junctions in vascular homeostasis, inflammation and angiogenesis
Wallez, Y., & Huber, P. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.09.003 · Cited by 473
Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways
Arbiser, J. L., Moses, M. A., Fernandez, C. A., Ghiso, N., Cao, Y., Klauber, N., Frank, D., Brownlee, M., Flynn, E., Parangi, S., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.3.861 · Cited by 469
Targeting the ANGPT–TIE2 pathway in malignancy
Huang, H., Bhat, A., Woodnutt, G., & Lappe, R. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2894 · Cited by 468
Witzenbichler, B., Maisonpierre, P. C., Jones, P., Yancopoulos, G. D., & Isner, J. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.29.18514 · Cited by 433
Marin-Hernandez, A., Gallardo-Perez, J., Ralph, S., Rodriguez-Enriquez, S., & Moreno-Sanchez, R. (2009) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955709788922610 · Cited by 433
Bone Morphogenetic Protein-9 Is a Circulating Vascular Quiescence Factor
David, L., Mallet, C., Keramidas, M., Lamandé, N., Gasc, J.-M., Dupuis-Girod, S., Plauchu, H., Feige, J.-J., & Bailly, S. (2008) · Circulation Research · doi:10.1161/circresaha.107.165530 · Cited by 416
Tumor Vessel Normalization by Chloroquine Independent of Autophagy
Maes, H., Kuchnio, A., Peric, A., Moens, S., Nys, K., De Bock, K., Quaegebeur, A., Schoors, S., Georgiadou, M., Wouters, J., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.06.025 · Cited by 410
The role of the Angiopoietins in vascular morphogenesis
Thomas, M., & Augustin, H. G. (2009) · Angiogenesis · doi:10.1007/s10456-009-9147-3 · Cited by 405
Purhonen, S., Palm, J., Rossi, D., Kaskenpää, N., Rajantie, I., Ylä-Herttuala, S., Alitalo, K., Weissman, I. L., & Salven, P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710516105 · Cited by 399
Mechanisms of Vessel Branching: Filopodia on Endothelial Tip Cells Lead the Way
De Smet, F., Segura, I., De Bock, K., Hohensinner, P. J., & Carmeliet, P. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.185165 · Cited by 397
The biology of hypoxia: the role of oxygen sensing in development, normal function, and disease
Giaccia, A. J., Simon, M. C., & Johnson, R. (2004) · Genes & Development · doi:10.1101/gad.1243304 · Cited by 380 · cited 1×
“their degradation by the proteasome [47, 48].”
The Molecular Basis of Vascular Lumen Formation in the Developing Mouse Aorta
Strilić, B., Kučera, T., Eglinger, J., Hughes, M. R., McNagny, K. M., Tsukita, S., Dejana, E., Ferrara, N., & Lammert, E. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.08.011 · Cited by 374
PECAM-1: regulator of endothelial junctional integrity
Privratsky, J. R., & Newman, P. J. (2014) · Cell and Tissue Research · doi:10.1007/s00441-013-1779-3 · Cited by 366
ALK1 Signaling Inhibits Angiogenesis by Cooperating with the Notch Pathway
Larrivée, B., Prahst, C., Gordon, E., del Toro, R., Mathivet, T., Duarte, A., Simons, M., & Eichmann, A. (2012) · Developmental Cell · doi:10.1016/j.devcel.2012.02.005 · Cited by 359
Self-citationKloepper, J., Riedemann, L., Amoozgar, Z., Seano, G., Susek, K., Yu, V., Dalvie, N., Amelung, R. L., Datta, M., Song, J. W., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1525360113 · Cited by 357
Cosse, J.-P., & Michiels, C. (2008) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152008785914798 · Cited by 348 · cited 1×
“Furthermore, hypoxic cells tend to be quiescent, making chemotherapy drugs that target proliferating cells ineffective [83].”
BackgroundPericytes limit tumor cell metastasis
Xian, X. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25705 · Cited by 345 · cited 1×
“Pericytes are an integral component of mature blood vessels, where they contribute to vascular quiescence and integrity [116], and tumor blood vessels frequently lack adequate pericyte coverage [117].”
BackgroundPark, J.-S., Kim, I.-K., Han, S., Park, I., Kim, C., Bae, J., Oh, S. J., Lee, S., Kim, J. H., Woo, D.-C., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.10.018 · Cited by 327 · cited 1×
“ABTAA enhanced the delivery of cisplatin into Lewis lung carcinoma tumors and consequently the overall survival of mice [135].”
BackgroundReview: Side Effects of Approved Molecular Targeted Therapies in Solid Cancers
Widakowich, C., de Castro, G., de Azambuja, E., Dinh, P., & Awada, A. (2007) · The Oncologist · doi:10.1634/theoncologist.12-12-1443 · Cited by 324
Peterson, T. E., Kirkpatrick, N. D., Huang, Y., Farrar, C. T., Marijt, K. A., Kloepper, J., Datta, M., Amoozgar, Z., Seano, G., Jung, K., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1525349113 · Cited by 317
Valdimarsdottir, G., Goumans, M.-J., Rosendahl, A., Brugman, M., Itoh, S., Lebrin, F., Sideras, P., & ten Dijke, P. (2002) · Circulation · doi:10.1161/01.cir.0000033830.36431.46 · Cited by 311
Kim, I., Kim, J.-H., Moon, S.-O., Kwak, H. J., Kim, N.-G., & Koh, G. Y. (2000) · Oncogene · doi:10.1038/sj.onc.1203800 · Cited by 306
Teichert-Kuliszewska, K. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00231-5 · Cited by 291
Guidance of Vascular Development: Lessons From the Nervous System
Larrivée, B., Freitas, C., Suchting, S., Brunet, I., & Eichmann, A. (2009) · Circulation Research · doi:10.1161/circresaha.108.188144 · Cited by 266
Tolaney, S. M., Boucher, Y., Duda, D. G., Martin, J. D., Seano, G., Ancukiewicz, M., Barry, W. T., Goel, S., Lahdenrata, J., Isakoff, S. J., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1518808112 · Cited by 258 · cited 1×
“Careful dosage of VEGF inhibitors can restore levels of angiogenic signals in tumors, leading to decreased permeability by tightening cell–cell junctions and by actively recruiting pericytes, resulting in increased tumor perfusion [103].”
BackgroundSkuli, N., Liu, L., Runge, A., Wang, T., Yuan, L., Patel, S., Iruela-Arispe, L., Simon, M. C., & Keith, B. (2009) · Blood · doi:10.1182/blood-2008-12-193581 · Cited by 255
Angiopoietin‐1 is an apoptosis survival factor for endothelial cells
Kwak, H. J., So, J.-N., Lee, S. J., Kim, I., & Koh, G. Y. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00378-6 · Cited by 239
Activation of the UNC5B receptor by Netrin-1 inhibits sprouting angiogenesis
Larrivée, B., Freitas, C., Trombe, M., Lv, X., DeLafarge, B., Yuan, L., Bouvrée, K., Bréant, C., Del Toro, R., Bréchot, N., et al. (2007) · Genes & Development · doi:10.1101/gad.437807 · Cited by 239
Self-citationSynergy and antagonism between Notch and BMP receptor signaling pathways in endothelial cells
Itoh, F., Itoh, S., Goumans, M., Valdimarsdottir, G., Iso, T., Dotto, G. P., Hamamori, Y., Kedes, L., Kato, M., & Dijke, P. T. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600065 · Cited by 237
Mast cells, angiogenesis, and tumour growth
Ribatti, D., & Crivellato, E. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.11.010 · Cited by 231
Filopodia are dispensable for endothelial tip cell guidance
Phng, L.-K., Stanchi, F., & Gerhardt, H. (2013) · Development · doi:10.1242/dev.097352 · Cited by 217
Effects of Angiopoietin-2-Blocking Antibody on Endothelial Cell–Cell Junctions and Lung Metastasis
Holopainen, T., Saharinen, P., D’Amico, G., Lampinen, A., Eklund, L., Sormunen, R., Anisimov, A., Zarkada, G., Lohela, M., Heloterä, H., et al. (2012) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djs009 · Cited by 216
Activin receptor–like kinase 1 is implicated in the maturation phase of angiogenesis
Lamouille, S., Mallet, C., Feige, J.-J., & Bailly, S. (2002) · Blood · doi:10.1182/blood.v100.13.4495 · Cited by 211
Driving Rho GTPase activity in endothelial cells regulates barrier integrity
Beckers, C., van Hinsbergh, V., & van Nieuw Amerongen, G. (2010) · Thrombosis and Haemostasis · doi:10.1160/th09-06-0403 · Cited by 209
Robo4 Maintains Vessel Integrity and Inhibits Angiogenesis by Interacting with UNC5B
Koch, A. W., Mathivet, T., Larrivée, B., Tong, R. K., Kowalski, J., Pibouin-Fragner, L., Bouvrée, K., Stawicki, S., Nicholes, K., Rathore, N., et al. (2011) · Developmental Cell · doi:10.1016/j.devcel.2010.12.001 · Cited by 209
Self-citationIdentification of Tek/Tie2 Binding Partners
Jones, N., Master, Z., Jones, J., Bouchard, D., Gunji, Y., Sasaki, H., Daly, R., Alitalo, K., & Dumont, D. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.43.30896 · Cited by 208
Low Doses of Ionizing Radiation Promote Tumor Growth and Metastasis by Enhancing Angiogenesis
Sofia Vala, I., Martins, L. R., Imaizumi, N., Nunes, R. J., Rino, J., Kuonen, F., Carvalho, L. M., Rüegg, C., Grillo, I. M., Barata, J. T., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011222 · Cited by 194
Hayes, A. J., Huang, W.-Q., Mallah, J., Yang, D., Lippman, M. E., & Li, L.-Y. (1999) · Microvascular Research · doi:10.1006/mvre.1999.2179 · Cited by 190
VEGF inhibition: insights from preclinical and clinical studies
Crawford, Y., & Ferrara, N. (2009) · Cell and Tissue Research · doi:10.1007/s00441-008-0675-8 · Cited by 188
Signalling pathways in vasculogenic mimicry
Paulis, Y. W. J., Soetekouw, P. M. M. B., Verheul, H. M. W., Tjan-Heijnen, V. C. G., & Griffioen, A. W. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.01.001 · Cited by 188
Hypoxia in tissue repair and fibrosis
Darby, I. A., & Hewitson, T. D. (2016) · Cell and Tissue Research · doi:10.1007/s00441-016-2461-3 · Cited by 188
Increased Risk of Serious Hemorrhage with Bevacizumab in Cancer Patients: A Meta-Analysis
Hapani, S., Sher, A., Chu, D., & Wu, S. (2010) · Oncology · doi:10.1159/000314980 · Cited by 185
Nasarre, P., Thomas, M., Kruse, K., Helfrich, I., Wolter, V., Deppermann, C., Schadendorf, D., Thurston, G., Fiedler, U., & Augustin, H. G. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3030 · Cited by 181
Current concepts in clinical radiation oncology
Orth, M., Lauber, K., Niyazi, M., Friedl, A. A., Li, M., Maihöfer, C., Schüttrumpf, L., Ernst, A., Niemöller, O. M., & Belka, C. (2014) · Radiation and Environmental Biophysics · doi:10.1007/s00411-013-0497-2 · Cited by 178
BMP-9 induces proliferation of multiple types of endothelial cells in vitro and in vivo
Suzuki, Y., Ohga, N., Morishita, Y., Hida, K., Miyazono, K., & Watabe, T. (2010) · Journal of Cell Science · doi:10.1242/jcs.061556 · Cited by 178
McCarty, M. F., Somcio, R. J., Stoeltzing, O., Wey, J., Fan, F., Liu, W., Bucana, C., & Ellis, L. M. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31334 · Cited by 175
Reengineering the Tumor Microenvironment to Alleviate Hypoxia and Overcome Cancer Heterogeneity
Martin, J. D., Fukumura, D., Duda, D. G., Boucher, Y., & Jain, R. K. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a027094 · Cited by 175
Contribution of marrow-derived progenitors to vascular and cardiac regeneration
Rafii, S., Meeus, S., Dias, S., Hattori, K., Heissig, B., Shmelkov, S. V., Rafii, D. C., & Lyden, D. C. (2002) · Seminars in Cell and Developmental Biology · doi:10.1006/scdb.2001.0285 · Cited by 173
Reis, M., Czupalla, C. J., Ziegler, N., Devraj, K., Zinke, J., Seidel, S., Heck, R., Thom, S., Macas, J., Bockamp, E., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20111580 · Cited by 167
Jayson, G. C., Parker, G. J. M., Mullamitha, S., Valle, J. W., Saunders, M., Broughton, L., Lawrance, J., Carrington, B., Roberts, C., Issa, B., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.032 · Cited by 165
Coxon, A., BREADY, J. V., Min, H., Kaufman, S., Leal, J., Yu, D., Lee, T. A., Sun, J.-R., Estrada, J., Bolon, B. N., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0213 · Cited by 158
ALK1-Fc Inhibits Multiple Mediators of Angiogenesis and Suppresses Tumor Growth
Mitchell, D., Pobre, E. G., Mulivor, A. W., Grinberg, A. V., Castonguay, R., Monnell, T. E., Solban, N., Ucran, J. A., Pearsall, R. S., Underwood, K. W., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0650 · Cited by 155
Tumor vasculogenic mimicry predicts poor prognosis in cancer patients: a meta-analysis
Yang, J., Liao, Y., Mai, D. M., Xie, P., Qiang, Y. Y., Zheng, L., Wang, M., Mei, Y., Meng, D., Xu, L., et al. (2016) · Angiogenesis · doi:10.1007/s10456-016-9500-2 · Cited by 154
Vascular permeability changes involved in tumor metastasis
García-Román, J., & Zentella‐Dehesa, A. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.03.005 · Cited by 149
Zentilin, L., Tafuro, S., Zacchigna, S., Arsic, N., Pattarini, L., Sinigaglia, M., & Giacca, M. (2006) · Blood · doi:10.1182/blood-2005-08-3215 · Cited by 147
Differential role of tissue factor pathway inhibitors 1 and 2 in melanoma vasculogenic mimicry.
Ruf, W., Seftor, E. A., Petrovan, R. J., Weiss, R. M., Gruman, L. M., Margaryan, N. V., Seftor, R. E. B., Miyagi, Y., & Hendrix, M. J. C. (2003) · PubMed · Cited by 146
Timke, C., Zieher, H., Roth, A. K., Hauser, K., Lipson, K. E., Weber, K. J., Debus, J., Abdollahi, A., & Huber, P. E. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1893 · Cited by 137
Govindarajan, B., Bai, X., Cohen, C., Zhong, H., Kilroy, S. M., Louis, G. W., Moses, M. A., & Arbiser, J. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212929200 · Cited by 130
Davis, G. E., Koh, W., & Stratman, A. N. (2007) · Birth Defects Research Part C Embryo Today Reviews · doi:10.1002/bdrc.20107 · Cited by 129
Intussusceptive microvascular growth in tumors
Ribatti, D., & Djonov, V. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.10.040 · Cited by 124
Young, S. D., & Hill, R. P. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.5.371 · Cited by 124
Bullen, J. W., Tchernyshyov, I., Holewinski, R. J., Devine, L. R., Wu, F., Venkatraman, V., KASS, D., Cole, R. N., Eyk, J. E. V., & Semenza, G. L. (2016) · Science Signaling · doi:10.1126/scisignal.aaf0583 · Cited by 123
Davis, G. E., & Bayless, K. J. (2003) · Microcirculation · doi:10.1038/sj.mn.7800175 · Cited by 122
Chakroborty, D., Sarkar, C., Yu, H., Wang, J., Liu, Z., Dasgupta, P., & Basu, S. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108696108 · Cited by 120
Goel, S., Gupta, N., Walcott, B. P., Snuderl, M., Kesler, C. T., Kirkpatrick, N. D., Heishi, T., Huang, Y., Martin, J. D., Ager, E., et al. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djt164 · Cited by 117
Machein, M. R., Renninger, S. L., Lima-Hahn, E. D., & Plate, K. H. (2003) · Brain Pathology · doi:10.1111/j.1750-3639.2003.tb00487.x · Cited by 116
Fan, F., Samuel, S., Gaur, P., Lu, J., Dallas, N. A., Xia, L., Bose, D., Ramachandran, V., & Ellis, L. M. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.81 · Cited by 109
Davis, I. D., Kiers, L., MacGregor, L., Quinn, M. A., Arezzo, J. C., Green, M., Rosenthal, M. A., Chia, M. M., Michael, M., Bartley, P., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1655 · Cited by 109
Endothelial Functions of Sphingosine-1-phosphate
Lucke, S., & Levkau, B. (2010) · Cellular Physiology and Biochemistry · doi:10.1159/000315109 · Cited by 107
Involvement of endothelial progenitor cells in tumor vascularization
Patenaude, A., Parker, J., & Karsan, A. (2010) · Microvascular Research · doi:10.1016/j.mvr.2010.01.007 · Cited by 103
Vascular Remodeling Marks Tumors That Recur During Chronic Suppression of Angiogenesis
Huang, J., Soffer, S. Z., Kim, E. S., McCrudden, K. W., Huang, J. T., New, T. N., Manley, C. A., Middlesworth, W., O’Toole, K., Yamashiro, D. J., et al. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.36.2.1 · Cited by 101
Mita, A. C., Takimoto, C. H. M., Mita, M. M., Tolcher, A. W., Sankhala, K. K., Sarantopoulos, J., Valdivieso, M., Wood, L., Rasmussen, E., Sun, Y., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-3368 · Cited by 101
van Meeteren, L. A., Thorikay, M., Bergqvist, S., Pardali, E., Stampino, C. G., Hu‐Lowe, D. D., Goumans, M., & ten Dijke, P. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.338103 · Cited by 100
Liu, J., Liao, S., Huang, Y., Samuel, R., Shi, T., Naxerova, K., Huang, P., Kamoun, W. S., Jain, R. K., Fukumura, D., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2456 · Cited by 98
Monk, B. J., Poveda, A., Vergote, I., Raspagliesi, F., Fujiwara, K., Bae, D.-S., Oaknin, A., Ray-Coquard, I., Provencher, D. M., Karlan, B. Y., et al. (2016) · Gynecologic Oncology · doi:10.1016/j.ygyno.2016.07.112 · Cited by 98
Bras, A. L., Lionneton, F., Mattot, V., Lelièvre, E., Caëtano, B., Spruyt, N., & Soncin, F. (2007) · Oncogene · doi:10.1038/sj.onc.1210566 · Cited by 97
Leow, C. C., Coffman, K., Inigo, I., Breen, S., Czapiga, M., Soukharev, S., Gingles, N., PETERSON, N., Fazenbaker, C., Woods, R., et al. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1366 · Cited by 95
Sacharidou, A., Stratman, A. N., & Davis, G. E. (2012) · Cells Tissues Organs · doi:10.1159/000331410 · Cited by 90
Oncogenes and tumor angiogenesis
Rak, J. W., & Yu, J. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2003.09.014 · Cited by 90
VE-cadherin and β-catenin binding dynamics during histamine-induced endothelial hyperpermeability
Guo, M., Breslin, J. W., Wu, M. H., Gottardi, C. J., & Yuan, S. Y. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.90607.2007 · Cited by 89
Nisancioglu, M. H., Betsholtz, C., & Genové, G. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4245 · Cited by 87
Kim, B. G., Gao, M., Kang, S., Choi, Y. P., Lee, J. H., Kim, J. E., Han, H. H., Mun, S. G., & Cho, N. H. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.73 · Cited by 87
Hypoxia‐induced resistance to doxorubicin and methotrexate in human melanoma cell lines in vitro
Sanna, K., & Rofstad, E. K. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910580219 · Cited by 84
Minimal Contribution of Marrow-Derived Endothelial Precursors to Tumor Vasculature
Larrivée, B., Niessen, K. S., Pollet, I. L., Corbel, S. Y., Long, M., Rossi, F. M. V., Olive, P. L., & Karsan, A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.5.2890 · Cited by 77
Self-citationTargeting pericytes with a PDGF-B aptamer in human ovarian carcinoma models
Lu, C., Shahzad, M. M. K., Moreno‐Smith, M., Lin, Y. G., Jennings, N. B., Allen, J. K., Landen, C. N., Mangala, L. S., Armaiz-Peña, G. N., Schmandt, R. E., et al. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.9.3.10635 · Cited by 75
Effect of Transient Hypoxia on Sensitivity to Doxorubicin in Human and Murine Cell Lines
Luk, C. K., Veinot-Drebot, L. M., Tjan, E., & Tannock, I. F. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.8.684 · Cited by 75
Paku, S., Dezső, K., Bugyik, E., Tóvári, J., Tı́már, J., Nagy, P., László, V., Klepetko, W., & Döme, B. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.05.033 · Cited by 72
Shen, J., Vil, M. D., Prewett, M. C., Damoci, C., Zhang, H., Li, H., Jimenez, X., Deevi, D. S., Iacolina, M. D., Kayas, A., et al. (2009) · Neoplasia · doi:10.1593/neo.09278 · Cited by 67
Liu, F., Wang, P., Jiang, X. L., Tan, G., Qiao, H., Jiang, H., Krissansen, G. W., & Sun, X. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00905.x · Cited by 65
Rostama, B., Turner, J. E., Seavey, G. T., Norton, C. R., Gridley, T., Vary, C., & Liaw, L. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.306541 · Cited by 64
Ribatti, D., Nico, B., Floris, C., Mangieri, D., Piras, F., Ennas, M. G., Vacca, A., & Sirigu, P. (2005) · PubMed · Cited by 63
Hijacking the vasculature in ccRCC—co-option, remodelling and angiogenesis
Qian, C.-N. (2013) · Nature Reviews Urology · doi:10.1038/nrurol.2013.26 · Cited by 62
Endothelial progenitor cells do not contribute to tumor endothelium in primary and metastatic tumors
Wickersheim, A., Kerber, M., de Miguel, L. S., Plate, K. H., & Machein, M. R. (2009) · International Journal of Cancer · doi:10.1002/ijc.24605 · Cited by 59
Falcón, B. L., Pietras, K., Chou, J., Chen, D., Sennino, B., Hanahan, D., & McDonald, D. M. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.02.019 · Cited by 56
Necchi, A., Giannatempo, P., Mariani, L., Farè, E., Raggi, D., Pennati, M., Zaffaroni, N., Crippa, F., Marchianò, A. V., Nicolai, N., et al. (2014) · Investigational New Drugs · doi:10.1007/s10637-014-0074-9 · Cited by 55
Regulation of vascular endothelial junction stability and remodeling through Rap1-Rasip1 signaling
Wilson, C. W., & Ye, W. (2014) · Cell Adhesion & Migration · doi:10.4161/cam.28115 · Cited by 51
Safety and Efficacy of 188-Rhenium-Labeled Antibody to Melanin in Patients with Metastatic Melanoma
Klein, M., Lotem, M., Peretz, T., Zwas, S. T., Mizrachi, S., Liberman, Y., Chisin, R., Schachter, J., Ron, I., Iosilevsky, G., et al. (2013) · Journal of Skin Cancer · doi:10.1155/2013/828329 · Cited by 48
Makker, V., Filiaci, V. L., Chen, L.-M., Darus, C. J., Kendrick, J. E., Sutton, G. P., Moxley, K. M., & Aghajanian, C. A. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.04.006 · Cited by 48
Agrawal, V., Maharjan, S., Kim, K., Kim, N., Son, J., Lee, K., Choi, H.-J., Rho, S.-S., Ahn, S., Won, M., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.1942 · Cited by 46
Larcher, F., Franco, M., Bolontrade, M. F., Rodríguez‐Puebla, M. L., Casanova, L., Navarro, M., Yancopoulos, G. D., Jorcano, J. L., & Conti, C. J. (2003) · Molecular Carcinogenesis · doi:10.1002/mc.10126 · Cited by 44
Davis, D. W., Takamori, R. K., Raut, C. P., Xiong, H. Q., Herbst, R. S., Stadler, W. M., Heymach, J. V., Demetri, G. D., Rashid, A., Shen, Y., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.678.11.2 · Cited by 43
Zhang, B., Shi, W., Jiang, T., Wang, L., Mei, H., Lu, H., Hu, Y., & Pang, Z. (2016) · Oncotarget · doi:10.18632/oncotarget.11546 · Cited by 41 · cited 2×
“micelles around 23 nm had a significantly more effective penetration and homogeneous distribution in tumor tissues [176].”
BackgroundDaskalow, K., Rohwer, N., Raskopf, E., Dupuy, É., Kühl, A. A., Loddenkemper, C., Wiedenmann, B., Schmitz, V., & Cramer, T. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0623-4 · Cited by 38
Kim, J., de Sampaio, P. C., Lundy, D. M., Peng, Q., Evans, K. W., Sugimoto, H., Gagea, M., Kienast, Y., do Amaral, N. S., Rocha, R. M., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.90733 · Cited by 36
Hypoxia Imaging Markers and Applications for Radiation Treatment Planning
Lin, A., & Hahn, S. M. (2012) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2012.04.002 · Cited by 35
Choi, S. H., Kwon, O., Park, J. Y., Kim, D. Y., Ahn, S. H., Kim, S. U., Ro, S. W., Kim, K. S., Park, J. H., Kim, S., et al. (2013) · Liver International · doi:10.1111/liv.12375 · Cited by 35
Wang, X., Solban, N., Khanna, P., Callea, M., Song, J., Alsop, D. C., Pearsall, R. S., Atkins, M. B., Mier, J. W., Signoretti, S., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9621 · Cited by 32
Chen, B., Lu, Y., Lin, C., Chen, T. W., Wu, P., Hsu, C., Yu, C., Wei, S., Cheng, A., & Shih, T. T. (2016) · BMC Cancer · doi:10.1186/s12885-016-2494-8 · Cited by 31
Kleibeuker, E. A., Fokas, E., Allen, P. D., Kersemans, V., Griffioen, A. W., Beech, J. S., Im, J. H., Smart, S., Castricum, K. C. M., van den Berg, J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12814 · Cited by 31
A Phase I study of CR002, a fully-human monoclonal antibody against platelet-derived growth factor-D
Hawthorne, T. R., Giot, L., Blake, L., et al. (2008) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp46236 · Cited by 28
A ‘tête-à tête’ between cancer stem cells and endothelial progenitor cells in tumor angiogenesis
Kaur, S., & Bajwa, P. (2013) · Clinical & Translational Oncology · doi:10.1007/s12094-013-1103-4 · Cited by 24
Involvement of Marrow-Derived Endothelial Cells in Vascularization
Larrivée, B., & Karsan, A. (2007) · Springer eBooks · doi:10.1007/978-3-540-68976-8_5 · Cited by 21
Self-citationBusk, M., & Horsman, M. R. (2013) · PubMed · Cited by 20
Activin Receptor Inhibitors—Dalantercept
Gupta, S., Gill, D. M., Pal, S. K., & Agarwal, N. (2015) · Current Oncology Reports · doi:10.1007/s11912-015-0441-5 · Cited by 14
Choi, S. H., Shin, H. W., Park, J. Y., Yoo, J. Y., Kim, D. Y., Ro, W. S., Yun, C., & Han, K. (2010) · The Korean Journal of Hepatology · doi:10.3350/kjhep.2010.16.3.280 · Cited by 14
Becker, S., Bohn, P., Bouyeure-Petit, A.-C., Modzelewski, R., Gensanne, D., Picquenot, J., Dubray, B. M., & Véra, P. (2015) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2015.08.002 · Cited by 12
Emerging mechanisms of vascular stabilization
LONDON, N. R., SMITH, M. C. P., & Li, D. Y. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03421.x · Cited by 12
Cited by
Combination strategies with PD-1/PD-L1 blockade: current advances and future directions
Yi, M., Zheng, X., Niu, M., Zhu, S., Ge, H., & Wu, K. (2022) · Molecular Cancer · doi:10.1186/s12943-021-01489-2 · Cited by 1,445
Angiogenic signaling pathways and anti-angiogenic therapy for cancer
Liu, Z.-L., Chen, H.-H., Zheng, L.-L., Sun, L.-P., & Shi, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01460-1 · Cited by 1,300
Targeting Tumor Microenvironment for Cancer Therapy
Roma-Rodrigues, C., Mendes, R., Baptista, P. V., & Fernandes, A. R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040840 · Cited by 1,187
The role of microenvironment in tumor angiogenesis
Jiang, X., Wang, J., Deng, X., Xiong, F., Zhang, S., Gong, Z., Li, X., Cao, K., Deng, H., He, Y., et al. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01709-5 · Cited by 761
Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges
Martin, J. D., Cabral, H., Stylianopoulos, T., & Jain, R. K. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0308-z · Cited by 682
Metadata
- Authors
- Viallard, C., & Larrivée, B.
- Venue
- Angiogenesis
- Published
- 2017-06-28
- Volume
- 20
- Issue
- 4
- Pages
- 409-426
- ISSN
- 0969-6970 (ISSN-L)
- 1573-7209
- OpenAlex
- W2731227355
- Cited by
- 1,424
- References
- 178
- FWCI
- 27.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.